Option Care Health (NASDAQ:OPCH) Posts Quarterly Earnings Results, Misses Expectations By $0.04 EPS

Option Care Health (NASDAQ:OPCH) released its earnings results on Tuesday. The company reported $0.42 earnings per share for the quarter, missing the consensus estimate of $0.46 by ($0.04), Zacks reports. Option Care Health had a net margin of 3.78% and a return on equity of 17.89%.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $36.09 on Tuesday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.56 and a quick ratio of 1.05. The business’s fifty day moving average price is $33.97 and its two-hundred day moving average price is $30.47. Option Care Health has a fifty-two week low of $24.24 and a fifty-two week high of $36.80. The stock has a market capitalization of $5.73 billion, a price-to-earnings ratio of 28.64, a price-to-earnings-growth ratio of 2.13 and a beta of 0.84.

Institutional Investors Weigh In On Option Care Health

Large investors have recently made changes to their positions in the company. McIlrath & Eck LLC acquired a new stake in shares of Option Care Health during the 2nd quarter worth about $37,000. Advisory Services Network LLC bought a new stake in Option Care Health during the third quarter worth about $35,000. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Option Care Health during the third quarter worth approximately $38,000. EverSource Wealth Advisors LLC increased its holdings in shares of Option Care Health by 528.1% during the second quarter. EverSource Wealth Advisors LLC now owns 1,407 shares of the company’s stock worth $46,000 after buying an additional 1,183 shares in the last quarter. Finally, Quarry LP raised its stake in shares of Option Care Health by 502.7% in the third quarter. Quarry LP now owns 1,549 shares of the company’s stock valued at $43,000 after acquiring an additional 1,292 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have commented on OPCH shares. National Bank Financial set a $37.00 price objective on Option Care Health in a research report on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft raised their target price on Option Care Health from $31.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Morgan Stanley lifted their price target on shares of Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 13th. TD Cowen reissued a “hold” rating on shares of Option Care Health in a report on Tuesday, January 27th. Finally, Wall Street Zen upgraded shares of Option Care Health from a “hold” rating to a “buy” rating in a research note on Saturday, January 10th. One analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $37.58.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.